|4Jul 2, 2:21 PM ET

Galena Biopharma, Inc. 4

4 · Galena Biopharma, Inc. · Filed Jul 2, 2014

Insider Transaction Report

Form 4
Period: 2014-06-30
Dunlap Ryan
Principal Accounting Officer
Transactions
  • Other

    Common Stock

    2014-06-30$2.60/sh+2,461$6,3997,804 total
Footnotes (1)
  • [F1]Pursuant to the Issuer's Employee Stock Purchase Plan.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT